Aditx Therapeutics Inc. (ADTX) Issues Shareholder Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Aditxt Issues Shareholder Update
April 17, 2023 7:00 AM EDTRICHMOND, Va--(BUSINESS WIRE)-- Aditxt,® Inc, (NASDAQ: ADTX) (Aditxt or the Company), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation programs and strategic M&A initiatives.
PEARSANTA, INC. (IMMUNE MONITORING)
Aditxts Pearsanta Designated as... More
